Last reviewed · How we verify
NCT03837639
Arm-crank Exercise Training on Cardiovascular Function of Patients With Peripheral Artery Disease
NA trial testing Arm ergometer in Peripheral Arterial Disease in 45 participants. Status unknown.
10 December 2022
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 10 June 2019 |
| Primary completion | 10 December 2022 |
| Estimated completion | 10 December 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Arm ergometer
- Treadmill ergometer
- Control group — full drug profile →
Conditions studied
- Peripheral Arterial Disease — all drugs for Peripheral Arterial Disease →
- Intermittent Claudication — all drugs for Intermittent Claudication →
- Hypertension — all drugs for Hypertension →
Sponsor
Hospital Israelita Albert Einstein
Who can join
Adults 45 to 85, any sex, with Peripheral Arterial Disease or Intermittent Claudication. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to analyze the effect of 12 weeks of arm crank exercise (ACE) training on cardiovascular function in PAD patients, and compare it with treadmill exercise (TE), the actual recommendation for this patients. In this clinical trial, 45 patients will be allocated randomly in three experimental groups: ACE training, TE and control group. ACE and TE groups will perform exercises twice a week with the intensity equivalent to 13- 15 on Borg's Subjective Perception Exertion Scale. Patients in control group will meet twice a week, however only to perform diverse activities and group living, without any type of exercise involved. All groups will be encouraged to increase their levels of activity, as they are usually guided in medical consultations. Before and after 12 weeks of intervention, cardiovascular function, functional capacity, cognition, and quality of life will be assessed.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Modes of exercise training for intermittent claudication.
Jansen SC, Abaraogu UO, Lauret GJ, Fakhry F, et al · · 2020 · cited 17× · PMID 32829481 · DOI 10.1002/14651858.cd009638.pub3 -
Effects of arm-crank exercise on cardiovascular function, functional capacity, cognition and quality of life in patients with peripheral artery disease: Study protocol for a randomized controlled trial.
Kanegusuku H, Correia MA, Longano P, Ritti-Dias RM, et al · · 2022 · PMID 35511887 · DOI 10.1371/journal.pone.0267849
Verify or expand the search:
- PubMed search for NCT03837639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Arm ergometer
Trials testing the same drug.
- NCT05032703 — Arm Ergometer Versus Stabilization Exercises on Trunk Control and Upper Extremity Functions in cp · NA · completed
Other recruiting trials for Peripheral Arterial Disease
Currently open trials in the same condition.
- NCT05437562 — Randomized Clinical Trial for Ewing Amputation in the VA · NA · recruiting
- NCT07427108 — Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety · NA · recruiting
- NCT07336381 — Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy · NA · recruiting
- NCT07076082 — Vascular Trial Associated Registry Pilot · Phase 4 · recruiting
- NCT06308562 — Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease · NA · recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03837639 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 7 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03837639.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing